
AD-Omics is a groundbreaking joint venture designed to revolutionize precision medicine diagnostic offerings across the Middle East.
AD-Omics will focus on implementing cutting-edge genomic and single-cell multi-omics technologies to deliver personalized healthcare solutions for the first time in the region, in alignment with the UAE’s vision of becoming a global leader in advanced healthcare, fostering innovation, and enhancing patient outcomes.
This strategic collaboration will combine IHLAD’s expertise in scientific healthy longevity with Singleron’s innovative technologies in single cell multi-omics to address the unique healthcare needs of the region.
WHAT WE DO
to guide personalized health improvement and transform the future of medicine,
one cell at a time.
OUR MISSION
Our goal is to study and improve the future of human health through the lens of single cell data, building the foundation for:
• Digital twins for individuals
• AI-driven drug development
• Personalized precision health management
AD-Omics' vision is a new era of healthcare where single cell multi-omics meets AI-driven insights to decode the complexity of human biology and power healthier, longer lives.
SCIENTIFIC PILLARS FOR HEALTHY LONGEVITY
Merging omics and lifestyle data for holistic understanding.
Through precision medicine tools and single cell technologies.
Through world-class multidisciplinary teams trusted from 4000+ labs in over
30 countries.

By gathering and deciphering single-cell multi-omics information and creating an AI-Powered virtual cell that holds your most accurate biological information, you can have your own 'digital twin' a dynamic, data-driven virtual replica of an individual.
Here's how it works:
The process begins by gathering a wide range of personal health data, including:
Doctors and AI systems can use the twin to:
This reduces trial-and-error in treatment and helps identify the most effective, personalized interventions.
This data is used to construct a “patient-in-silico”—a virtual model that mirrors your biological systems. It simulates how your body functions and how it might respond to different conditions or treatments.
As new data comes in, the digital twin updates continuously. This keeps the model accurate and reflective of your current health status
The digital twin provides tailored recommendations for:
This enables precision medicine 2.0, care that is uniquely suited to your biology and life context.
Chief Executive Officer, IHLAD
...The launch of AD-Omics is a significant milestone in our mission to make these groundbreaking advancements accessible to patients across the Middle East.
Together, we aim to revolutionize how diseases are understood and treated, giving patients access to personalized treatments that improve quality of life and longevity.”


Founder & Chief Executive Officer, Singleron Biotechnologies
Our mission has always been to make single cell technologies widely available for better healthcare solutions.
By partnering with IHLAD on AD-Omics, we are not only expanding our footprint into the Middle East but also ensuring that our innovations are utilized to their fullest potential to transform lives.”
Aging is more than just getting older—it's a complex biological process driven by molecular changes, a decline in system integrity, and functional deterioration that can lead to disease, disability, and even mortality.
But what if you could see it coming—and do something about it?
With cutting-edge single-cell resolution data, we can now create your Digital Twin—a dynamic, personalized model of your biology. This breakthrough empowers Personalized Precision Medicine, offering health strategies tailored specifically to you and moreover:
Your future is personal.
Your health should be too.